Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice
Chenxi Qiu(Chinese Academy of Sciences), Kun Ping Lu(University of North Carolina at Chapel Hill), Alexander Rotenberg(Boston Children's Hospital), Joseph E. Stucky(Beth Israel Deaconess Medical Center), Megan K. Herbert(Beth Israel Deaconess Medical Center), Xiao Zhen Zhou(Western University), Barbara J. Caldarone(Brigham and Women's Hospital), Kazuo Washida(National Cerebral and Cardiovascular Center), Yu‐Min Lin(Beth Israel Deaconess Medical Center), Peter A. Angeli(Harvard University), Mahmoud A. Bassal(Harvard University), Sean Baxley(Beth Israel Deaconess Medical Center), Asami Kondo(Beth Israel Deaconess Medical Center), Daniel G. Tenen(Harvard University), Ken Arai(Massachusetts General Hospital), Yan Sun(South Central University for Nationalities), Eileen H. Bigio(Northwestern University), Mark L. Zeidel(Brigham and Women's Hospital), Eng H. Lo(Harvard University), Xiaochun Chen(Shenzhen University), Cheng-yu Tsai(Beth Israel Deaconess Medical Center), Na‐Mi Kim(Beth Israel Deaconess Medical Center), Önder Albayram(Medical University of South Carolina), Bin Wang(Dalian Medical University), Shingo Kozono(Beth Israel Deaconess Medical Center)
Cited by 67
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
The Science of Stroke: Mechanisms in Search of Treatments
|Neuron|2010|1.9k